Putnam Biorevolution ETFSYNBETF
13F holders, Q1 2025 (March 31)4holders
0new positions
0sold out
$27.98avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Putnam Biorevolution ETF (SYNB) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Franklin Resources Inc. ($3.5M), Royal Bank of Canada ($59K) and UBS Group AG ($364).
- Company
- Putnam Biorevolution ETF
- CUSIP
- 746729805
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 2 shares bought and 2,410 shares sold, net −2,408 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Franklin Resources Inc. | 0.00% | No change | 125,000 | $3.5M |
| Royal Bank of Canada | 0.00% | Reduce -53.3% | 2,108 | $59K |
| UBS Group AG | 0.00% | Add +18.2% | 13 | $364 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $55 |
"% of holder's portfolio" is SYNB's weight in each manager's 13F, not the share of Putnam Biorevolution ETF the manager owns.